Is High Blood Pressure Genetic? What Your DNA Reveals

Nearly half of all American adults - 47.7% - have high blood pressure (Ostchega et al., 2024). Globally, the number has more than doubled from 650 million in 1990 to 1.4 billion today (World Health Organization, 2024). If your parents had hypertension, you've probably wondered: is this coming for me too?

The short answer is yes - genetics play a significant role. Studies estimate that 30% to 50% of blood pressure variation is heritable (Evangelou et al., 2018; Kato et al., 2015). But hypertension is not a single-gene condition like sickle cell disease. It's polygenic, meaning hundreds or even thousands of small genetic effects combine with lifestyle factors to determine your risk. The good news? Even with a strong genetic predisposition, your choices still matter enormously.

How Many Genes Affect Blood Pressure?

A landmark 2024 genome-wide association study (GWAS) analyzing over 1 million people of European ancestry identified 2,103 independent genetic signals associated with blood pressure, including 113 novel loci never reported before (Keaton et al., 2024). Earlier GWAS efforts had already catalogued over 1,000 loci (Evangelou et al., 2018; Warren et al., 2017).

Think of it like height. No single gene makes you tall or short - thousands of variants each nudge you a few millimeters in one direction. Blood pressure works the same way. Each variant might shift your systolic pressure by only 0.5 to 1 mmHg, but stack enough of them together and the cumulative effect becomes clinically meaningful (Ehret et al., 2016).

This is why polygenic risk scores - calculations that aggregate the effects of thousands of variants - are becoming increasingly useful for predicting hypertension risk. Learn more about how polygenic risk scores work.

Key Genes Linked to Hypertension

While blood pressure is polygenic, certain genes have outsized effects and are well-studied enough to be clinically informative:

AGT (Angiotensinogen) - rs699 (M235T)

The AGT gene encodes angiotensinogen, a precursor protein in the renin-angiotensin-aldosterone system (RAAS) - your body's primary blood pressure regulation pathway. The M235T variant (rs699) increases circulating angiotensinogen levels by approximately 10–20%, which raises blood pressure (Jeunemaitre et al., 1992).

About 64% of Americans carry at least one copy of the T allele, and these carriers are more sensitive to dietary sodium (Hunt et al., 1998). In carriers, reducing salt intake lowers blood pressure more effectively than in non-carriers - a key example of how genetics can personalize dietary advice.

ACE (Angiotensin-Converting Enzyme) - Insertion/Deletion Polymorphism

The ACE gene contains a well-known insertion/deletion (I/D) polymorphism. The D allele is associated with higher ACE activity and higher blood pressure (Rigat et al., 1990). People with the DD genotype have roughly twice the circulating ACE levels compared to those with II (Tiret et al., 1992).

This is particularly relevant for pharmacogenomics: ACE inhibitors (lisinopril, enalapril, ramipril) target this exact enzyme. Explore how your DNA affects drug response.

ADD1 (Alpha-Adducin) - rs4961 (Gly460Trp)

The ADD1 gene encodes a protein involved in kidney sodium reabsorption. The Trp460 variant (rs4961) enhances sodium reabsorption in the renal tubules, contributing to salt-sensitive hypertension (Cusi et al., 1997). Carriers of this variant tend to respond better to diuretic medications like hydrochlorothiazide.

CYP11B2 (Aldosterone Synthase) - rs1799998

This gene controls aldosterone production - the hormone that tells your kidneys to retain sodium and water. Certain variants lead to higher aldosterone levels and increased blood pressure (Brand et al., 1998). Elevated aldosterone is the mechanism behind a subset of resistant hypertension cases.

NOS3 (Nitric Oxide Synthase 3) - rs1799983

Nitric oxide is a powerful vasodilator - it relaxes blood vessel walls and lowers pressure. Variants in NOS3 reduce nitric oxide production, impairing this natural pressure-lowering mechanism (Miyamoto et al., 1998). The Glu298Asp variant (rs1799983) has been associated with a 30–40% increased risk of hypertension in multiple meta-analyses (Niu & Bhatt, 2018).

Salt Sensitivity: Where Genetics Meets Diet

One of the most actionable insights from blood pressure genetics is salt sensitivity. Not everyone's blood pressure responds equally to sodium intake. An estimated 25–50% of people with normal blood pressure and up to 50–60% of those with hypertension are salt-sensitive (Weinberger, 1996).

Genetic variants in AGT, ADD1, ACE, and several other genes contribute to this variability. If your DNA shows variants associated with salt sensitivity, reducing sodium to below 2,300 mg per day (the American Heart Association's guideline) - or even below 1,500 mg - may have a substantially larger impact on your blood pressure than it would for someone without these variants (Elijovich et al., 2016).

This is exactly the kind of personalized insight that raw DNA analysis can provide. Upload your DNA data to see your genetic blood pressure profile.

The Lifestyle Factor: Genes Are Not Destiny

Here's the critical nuance: even with a high genetic risk for hypertension, lifestyle modifications can dramatically reduce your actual risk.

A large study of over 300,000 UK Biobank participants found that individuals with high genetic risk who maintained a healthy lifestyle (regular exercise, healthy BMI, limited alcohol, no smoking) had a 30% lower risk of developing hypertension compared to those with the same genetic risk but unhealthy habits (Pazoki et al., 2018).

What you can do:

• Exercise regularly - 150 minutes per week of moderate aerobic activity can lower systolic BP by 5–8 mmHg (Whelton et al., 2018)
• Reduce sodium intake - especially important if you carry salt-sensitive variants
• Maintain a healthy weight - each 1 kg of weight loss reduces systolic BP by approximately 1 mmHg (Neter et al., 2003)
• Follow the DASH diet - rich in fruits, vegetables, whole grains, and low-fat dairy; shown to reduce systolic BP by 8–14 mmHg (Sacks et al., 2001)
• Limit alcohol - no more than 1 drink per day for women, 2 for men
• Manage stress - chronic stress activates the sympathetic nervous system, raising BP

How Genetic Testing Can Help

Knowing your genetic predisposition doesn't just satisfy curiosity - it enables precision prevention. If your DNA reveals:

• High polygenic risk → start monitoring blood pressure earlier and more frequently
• Salt-sensitive variants (AGT, ADD1) → prioritize aggressive sodium reduction
• ACE-related variants → discuss ACE inhibitor responsiveness with your doctor
• NOS3 variants → focus on nitric oxide–boosting strategies (exercise, beetroot juice, leafy greens)

GenomeInsight analyzes over 500 genetic variants across health, pharmacogenomics, and more - including the blood pressure–related genes discussed here. Check your genetic health risks or explore our pricing plans.

Stay informed - subscribe to our newsletter for the latest in genomic health research.

Key Takeaways

• Blood pressure is 30–50% heritable, driven by thousands of genetic variants acting together
• Over 2,100 genetic loci have been linked to blood pressure in the largest GWAS to date
• Key genes include AGT, ACE, ADD1, CYP11B2, and NOS3 - each affecting different parts of the blood pressure regulation system
• Salt sensitivity is partly genetic - your DNA can reveal whether sodium reduction will be especially effective for you
• Genes are not destiny - a healthy lifestyle can reduce hypertension risk by 30% even in genetically predisposed individuals
• Genetic testing enables precision prevention, helping you tailor diet, exercise, and medication strategies to your DNA

References

Brand, E., Chatelain, N., Mulatero, P., Féry, I., Curnow, K., Jeunemaitre, X., Gramine, P., Pascoe, L., Zennaro, M. C., & Plouin, P. F. (1998). Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension, 32(2), 198–204. https://doi.org/10.1161/01.HYP.32.2.198

Cusi, D., Barlassina, C., Azzani, T., Casari, G., Citterio, L., Devoto, M., Glorioso, N., Lanzani, C., Manunta, P., Righetti, M., Rivera, R., Stella, P., & Bianchi, G. (1997). Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. The Lancet, 349(9062), 1353–1357. https://doi.org/10.1016/S0140-6736(97)01029-3

Ehret, G. B., Ferreira, T., Chasman, D. I., Jackson, A. U., Schmidt, E. M., Johnson, T., & International Consortium for Blood Pressure. (2016). The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nature Genetics, 48(10), 1171–1184. https://doi.org/10.1038/ng.3667

Elijovich, F., Weinberger, M. H., Anderson, C. A., Appel, L. J., Bursztyn, M., Cook, N. R., Dart, R. A., Newton-Cheh, C., Sacks, F. M., & Laffer, C. L. (2016). Salt sensitivity of blood pressure: A scientific statement from the American Heart Association. Hypertension, 68(3), e7–e46. https://doi.org/10.1161/HYP.0000000000000047

Evangelou, E., Warren, H. R., Mosen-Ansorena, D., Mifsud, B., Pazoki, R., Gao, H., & Million Veteran Program. (2018). Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nature Genetics, 50(10), 1412–1425. https://doi.org/10.1038/s41588-018-0205-x

Hunt, S. C., Cook, N. R., Oberman, A., Cutler, J. A., Hennekens, C. H., Allender, P. S., Walker, W. G., Whelton, P. K., & Williams, R. R. (1998). Angiotensinogen genotype, sodium reduction, blood pressure, and cardiovascular disease. Hypertension, 32(3), 393–401. https://doi.org/10.1161/01.HYP.32.3.393

Jeunemaitre, X., Soubrier, F., Kotelevtsev, Y. V., Lifton, R. P., Williams, C. S., Charru, A., Hunt, S. C., Hopkins, P. N., Williams, R. R., Lalouel, J. M., & Corvol, P. (1992). Molecular basis of human hypertension: Role of angiotensinogen. Cell, 71(1), 169–180. https://doi.org/10.1016/0092-8674(92)90275-H

Kato, N., Loh, M., Takeuchi, F., Verweij, N., Wang, X., Zhang, W., & Chambers, J. C. (2015). Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nature Genetics, 47(11), 1282–1293. https://doi.org/10.1038/ng.3405

Keaton, J. M., Kamali, Z., Engmann, J., Madhavan, S., Madhavan, S., Vaez, A., & International Consortium of Blood Pressure. (2024). Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits. Nature Genetics, 56(5), 778–791. https://doi.org/10.1038/s41588-024-01714-w

Miyamoto, Y., Saito, Y., Kajiyama, N., Yoshimura, M., Shimasaki, Y., Nakayama, M., Kamitani, S., Harada, M., Ishikawa, M., Kuwahara, K., Ogawa, E., Hamanaka, I., Takahashi, N., Kaneshige, T., Teraoka, H., Akamizu, T., Azuma, N., Yoshimasa, Y., Yoshimasa, T., … Nakao, K. (1998). Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension, 32(1), 3–8. https://doi.org/10.1161/01.HYP.32.1.3

Neter, J. E., Stam, B. E., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M. (2003). Influence of weight reduction on blood pressure: A meta-analysis of randomized controlled trials. Hypertension, 42(5), 878–884. https://doi.org/10.1161/01.HYP.0000094221.86888.AE

Niu, W., & Bhatt, D. L. (2018). Endothelial nitric oxide synthase gene Glu298Asp polymorphism and hypertension: A meta-analysis of 53 studies. Journal of Human Hypertension, 32(4), 244–257.

Ostchega, Y., Fryar, C. D., Nwankwo, T., & Nguyen, D. T. (2024). Hypertension prevalence among adults aged 18 and over: United States, August 2021–August 2023. NCHS Data Brief, (511), 1–8.

Pazoki, R., Dehghan, A., Evangelou, E., Warren, H., Gao, H., Caulfield, M., Elliott, P., & Tzoulaki, I. (2018). Genetic predisposition to high blood pressure and lifestyle factors. Circulation, 137(3), 653–661. https://doi.org/10.1161/CIRCULATIONAHA.117.030898

Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Journal of Clinical Investigation, 86(4), 1343–1346. https://doi.org/10.1172/JCI114844

Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., Karanja, N., Lin, P. H., & DASH-Sodium Collaborative Research Group. (2001). Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. New England Journal of Medicine, 344(1), 3–10. https://doi.org/10.1056/NEJM200101043440101

Tiret, L., Rigat, B., Visvikis, S., Breda, C., Corvol, P., Cambien, F., & Soubrier, F. (1992). Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. American Journal of Human Genetics, 51(1), 197–205.

Warren, H. R., Evangelou, E., Cabrera, C. P., Gao, H., Ren, M., Mifsud, B., & International Consortium of Blood Pressure Genome-Wide Association Studies. (2017). Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nature Genetics, 49(3), 403–415. https://doi.org/10.1038/ng.3768

Weinberger, M. H. (1996). Salt sensitivity of blood pressure in humans. Hypertension, 27(3), 481–490. https://doi.org/10.1161/01.HYP.27.3.481

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., & Wright, J. T. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Journal of the American College of Cardiology, 71(19), e127–e248. https://doi.org/10.1016/j.jacc.2017.11.006

World Health Organization. (2024). Hypertension fact sheet. https://www.who.int/news-room/fact-sheets/detail/hypertension

---

Related Reading

• heart disease genetics
• atrial fibrillation